DEUTSCHE BANK AG\ - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,336,144
-71.7%
324,294
-32.2%
0.01%
-65.2%
Q2 2023$43,579,142
+10.2%
478,366
-20.2%
0.02%
+4.5%
Q1 2023$39,538,271
+190.5%
599,428
+127.8%
0.02%
+175.0%
Q4 2022$13,608,883
-64.9%
263,177
-53.6%
0.01%
-65.2%
Q3 2022$38,776,000
+23.5%
567,745
-18.3%
0.02%
+27.8%
Q2 2022$31,410,000
+13.6%
694,607
+27.6%
0.02%
+38.5%
Q1 2022$27,657,000
+72.7%
544,311
+60.7%
0.01%
+85.7%
Q4 2021$16,015,000
+67.0%
338,753
+16.4%
0.01%
+40.0%
Q3 2021$9,591,000
-52.6%
291,009
-9.0%
0.01%
-50.0%
Q2 2021$20,221,000
+12.3%
319,961
-23.8%
0.01%0.0%
Q1 2021$18,007,000
-50.3%
419,660
-33.8%
0.01%
-54.5%
Q4 2020$36,250,000
+115.6%
633,737
+13.7%
0.02%
+83.3%
Q3 2020$16,812,000
-5.6%
557,231
+2.2%
0.01%
-14.3%
Q2 2020$17,803,000
+258.4%
545,087
+193.9%
0.01%
+250.0%
Q1 2020$4,968,000
-1.6%
185,442
+12.4%
0.00%
+33.3%
Q4 2019$5,050,000
+60.4%
165,010
+26.2%
0.00%
+50.0%
Q3 2019$3,148,000
+8.7%
130,763
+14.3%
0.00%0.0%
Q2 2019$2,896,000
+16.5%
114,364
-10.3%
0.00%
+100.0%
Q1 2019$2,485,000
+624.5%
127,516
+388.8%
0.00%
Q4 2018$343,000
-90.2%
26,085
-86.8%
0.00%
-100.0%
Q3 2018$3,516,000
+25.5%
197,857
+55.3%
0.00%0.0%
Q2 2018$2,802,000
+783.9%
127,397
+785.7%
0.00%
Q1 2018$317,000
-38.6%
14,384
-39.6%
0.00%
Q4 2017$516,00023,8080.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders